Article

AJMC® in the Press, November 10, 2017

Author(s):

AJMC Staff

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

A news article by The American Journal of Managed Care® was highlighted in Tuesday’s CER Daily Newsfeed from the National Pharmaceutical Council. The article, “New Framework Provides Direction for Implementing Accountable Care Reform,” described a comprehensive framework that can be used to optimize integration of accountable care by drawing cross-country comparisons in Nepal, the Netherlands, and Germany.

Related Videos
Eva Svigethy, MD, PhD, and Ben Cohen, MD
ATS 2025
Bridgette J. Picou, LVN, ACLPN, The Well Project
John Barkett, MBA
1 expert in this video
Dr Gerard Criner
Emma Achola-Kothari, PhD
Related Content
Poor air quality. | Image Credit: tonjung- stock.adobe.com
May 24th 2025

Skin Diseases and Aging Linked to Air Pollution

Cameron Santoro
Air pollution significantly contributes to and worsens various dermatologic conditions through oxidative stress, inflammation, and disruption of the skin barrier.
Managed Care Cast
May 20th 2025

Mental Health Awareness: Transforming Workplace Support and Engagement

Giuliana Grossi Jim Kinville
Explore how employers enhance workplace mental health by fostering a culture of support and engagement, focusing on holistic well-being strategies in this interview with Jim Kinville, MA, University of Pittsburgh Medical Center.
Joe Biden | Image credit: ABC News
May 23rd 2025

News Reports on Biden’s Prostate Cancer Reflect Controversy, Limits of PSA Testing

Mary Caffrey
Following former President Joe Biden's diagnosis with metastatic prostate cancer, news coverage has focused on his lack of prostate-specific antigen (PSA) screening over the past decade.
managed care cast logo
May 13th 2025

Inside the Center's MDD Value Model and Its Use of Dynamic Pricing

Brooke McCormick Larragem Raines, MS
Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Based on western blot testing, patients who received gene therapy at 2 years old showed a mean dystrophin expression of 93.87% of normal. | Image Credit: Treecha - stock.adobe.com
May 23rd 2025

DMD Gene Therapy Shows Efficacy, Safety in Patients Treated at 2 Years Old

Rose McNulty
Delandistrogene moxeparvovec, a gene therapy for Duchenne muscular dystrophy (DMD), showed high dystrophin expression and a favorable safety profile in young patients.
Crohn's disease and guselkumab | Image credit: New Africa - stock.adobe.com
May 23rd 2025

Guselkumab Demonstrates Rapid and Lasting Results in Crohn Disease

Guselkumab shows significant clinical and endoscopic benefits for adults with moderate to severe Crohn disease, offering a promising treatment alternative.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo